Physician profile
John D Sobiesk
NPI 1508975178
$1,415.94
in general payments reported to CMS, 2019-2025
17 companies · $432 in 2025
The $432 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $222 · 2020: $136 · 2021: $131 · 2022: $177 · 2023: $189 · 2024: $129 · 2025: $432.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $716 · Education: $34.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $716.35 |
| Education | $34.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $432.71 | 2020-2025 | Dupixent, Libtayo |
| Stryker Corporation | $310.01 | 2019-2025 | Xpress Loprofile, Scopis Ent, Xpress Ent Dilation System |
| Optinose US, INC. | $119.09 | 2019-2023 | |
| Glaxosmithkline, LLC. | $70.64 | 2025 | Nucala |
| Aerin Medical INC. | $67.03 | 2024-2025 | |
| Amgen INC. | $58.97 | 2025 | Tezspire |
| Olympus America INC. | $57.53 | 2019-2022 | |
| Inspire Medical Systems, INC. | $49.10 | 2023-2025 | Inspire |
| Astrazeneca Pharmaceuticals Lp | $49.08 | 2025 | Tezspire |
| Kaleo, INC. | $43.63 | 2022 | |
| Genzyme Corporation | $38.86 | 2020-2021 | |
| Medtronic, INC. | $36.36 | 2022-2024 | Propel |
| Merck Sharp & Dohme LLC | $23.49 | 2023 | Verquvo |
| Intersect Ent, INC. | $20.09 | 2020 | |
| Novartis Pharmaceuticals Corporation | $14.64 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hikma Pharmaceuticals USA | $13.59 | 2023 | Ryaltris |
| Arbor Pharmaceuticals, INC. | $11.12 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Sobiesk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.